Dew, if higher GT1 sales for Gilead is bearish for Enanta, I am not clear how analysts can revise sales and share upward for ABBV ? Could initial trejectory not representative of steady state for years to come for both Gilead and ABBV ? T.I.A
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.